Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
暂无分享,去创建一个
V. Tapson | S. Dohad | O. Friedman | Siddharth Singh | M. Yaqoob | Y. Matusov | J. Steinberger | Siddharth Singh | Oren Friedman | Angelena Lopez | Yuri Matusov | Maidah Yaqoob | Anya Karumanchi | H Gabriel Lipshutz | Suhail Dohad | Jonathan Steinberger | Angelena Lopez | Victor F Tapson | Anya Karumanchi | H. G. Lipshutz
[1] G. Jacobsen,et al. Ultrasound-assisted catheter-directed thrombolysis versus anticoagulation alone for management of submassive pulmonary embolism. , 2022, Journal of cardiology.
[2] S. Goldhaber,et al. Ultrasound-facilitated, catheter-directed thrombolysis versus anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study. , 2022, American heart journal.
[3] E. Vicaut,et al. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial , 2021, Thrombosis and Haemostasis.
[4] S. Stevens,et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report - Executive Summary. , 2021, Chest.
[5] OUP accepted manuscript , 2021, European Heart Journal.
[6] M. Humbert,et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.
[7] E. Vicaut,et al. Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial , 2018, Clinical Research in Cardiology.
[8] S. Solomon,et al. Right Ventricular Function, Right Ventricular–Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) Study , 2018, JAMA cardiology.
[9] E. Vicaut,et al. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. , 2017, Journal of the American College of Cardiology.
[10] F. Klok,et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature , 2017, European Respiratory Journal.
[11] J. Kline,et al. Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: Systematic review with meta-analysis , 2017, Vascular medicine.
[12] T. Sundt,et al. A Multidisciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience With a Novel Approach to Delivery of Care to Patients With Submassive and Massive Pulmonary Embolism. , 2016, Chest.
[13] M. D. de Gregorio,et al. Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): Initial Results From a Prospective Multicenter Registry. , 2015, Chest.
[14] S. Goldhaber,et al. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. , 2015, JACC. Cardiovascular interventions.
[15] Simon Gibbs,et al. [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.
[16] M. Revel,et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism , 2014, Thrombosis and Haemostasis.
[17] J. Kline,et al. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial , 2014, Journal of thrombosis and haemostasis : JTH.
[18] Ralf-Thorsten Hoffmann,et al. Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism , 2014, Circulation.
[19] M. Sharifi,et al. Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). , 2013, The American journal of cardiology.
[20] J. Kline,et al. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. , 2009, Chest.
[21] J. Kline,et al. Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. , 2007, European heart journal.
[22] S. Vanni,et al. Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events. , 2006, Archives of internal medicine.
[23] L. Jorfeldt,et al. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. , 1999, Circulation.